Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Rheumatology Reports
Published in: Current Rheumatology Reports 8/2014

01-08-2014 | Osteoporosis and Metabolic Bone Disease (KG Saag, Section Editor)

Use of DXA-Based Technology for Detection and Assessment of Risk of Vertebral Fracture in Rheumatology Practice

Author: Michael Maricic

Published in: Current Rheumatology Reports | Issue 8/2014

Login to get access

Abstract

Measurement of bone mineral density (BMD) by dual-energy X-ray absorptiometry (DXA) is the recommended method for diagnosis of osteoporosis and assessment of future fracture risk. However, most patients who will suffer fractures do not have osteoporosis by DXA (T-score of −2.5 or less). Bone strength, which is most closely associated with resistance to fracture, is a composite of both bone density and bone quality, and the latter is not measured by DXA. Thus, other technology is needed for non-invasive and inexpensive assessment of bone strength and fracture risk. Vertebral fractures, the most common clinical fracture in the general population, are of even greater importance in rheumatoid arthritis and other rheumatic disorders. Vertebral fracture assessment (VFA) and trabecular bone scores (TBS), two techniques which can aid prediction of future fracture risk, can be used with currently available DXA machines. Description of these techniques and their potential application to clinical rheumatology practice will be the focus of this paper.
Literature
1.
NIH consensus development panel on osteoporosis prevention, diagnosis and therapy. Osteoporosis prevention diagnosis and therapy JAMA. 2001;285(6):785–96.
2.
Kanis JA, Melton III LJ, Christiansen C, et al. The diagnosis of osteoporosis. J Bone Miner Res. 1994;9:1137–41.PubMedCrossRef
3.
Boutroy S, Bouxsein ML, Munoz F, et al. In vivo assessment of bone microstructure by high resolution peripheral computed tomography. J Clin Endocrinol Metab. 2005;90(12):6508–15.PubMedCrossRef
4.
Phan CM, Matsura M, Bauer JS, et al. Trabecular bone structure of the calcaneus: comparison of MR images at 3.0 and 1.5 T with micro-CT as the standard of reference. Radiology. 2006;488–96.
5.
Lam SCB, Wald MJ, Rajapkse CS, et al. Performance of the MRI-Based virtual bone biopsy in the distal radius: serial reproducibility and reliability of structural and mechanical parameters in women representative of osteoporosis study populations. Bone. 2001;39(4):895–903.
6.
Naylor KE, McClosky EV, Eastell R, et al. Use of DXA based finite element analysis of the proximal femur in a longitudinal study of hip fracture. J Bone Miner Res. 2013;28:1014–21.PubMedCrossRef
7.
Kanis JA, on behalf of the World Health Organization Scientific Group. Assessment of osteoporosis at the primary health-care level. Technical report. Geneva: World Health Organization; 2007.
8.
Ross PD, Davis JW, Epstein RS, et al. Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Arch Int Med. 1991;114:919–23.
9.
Melton LJ, Atkinson EJ, Cooper C, et al. Vertebral fractures predict subsequent fractures. Osteoporos Int. 1999;10:214–21.PubMedCrossRef
10.
Cauley JA, Hochberg MC, Lui LY, et al. Long-term risk of incident vertebral fractures. JAMA. 2007;298(23):2761–8.PubMedCrossRef
11.
Ensrud KE, Thompson DE, Cauley JA, et al. Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. J Am Geriatr Soc. 2000;48:241–9.PubMed
12.
Fink HA, Milavetz DL, Palermo L, et al. What proportion of incident radiographic vertebral deformities is clinically diagnosed and vice versa. J Bone Miner Res. 2005;20(7):1216–22.PubMedCrossRef
13.
Orstavik RE, Haugeberg G, Mowinckel P, et al. Vertebral deformities of rheumatoid arthritis: a comparison with population based controls. Arch Int Med. 2004;164:420–5.CrossRef
14.
Van Staa TP, Guesens P, Bijlsma JW, et al. Clinical assessment of long-term risk of fracture and patients with rheumatoid arthritis. Arthritis Rheum. 2006;54:3104–12.PubMedCrossRef
15.
de Nijs RNJ, Jacobs JWG, Bijlsma JWJ, et al. Prevalence of vertebral deformities and symptomatic vertebral fractures in corticosteroid treated patients with rheumatoid arthritis. Rheumatology. 2001;40:1375–83.PubMedCrossRef
16.
Orstavik RE, Haugeberg G, Uhlig T, et al. Incidence of vertebral deformities and 225 female rheumatoid arthritis patients measured by morphometric X-ray absorptiometry. Osteoporos Int. 2005;16:35–42.PubMedCrossRef
17.
Pell NF, Moore DJ, Barrington NA, et al. Risk of vertebral fracture and relation to bone mineral density in steroid treated patients with rheumatoid arthritis. Ann Rheum Dis. 1995;54:801–6.CrossRef
18.
Lodder MC, Haugeberg G, Lems WF, et al. Radiographic damage associated with low bone mineral density and vertebral deformities and rheumatoid arthritis. The Oslo-Trulo-Amsterdam (OSTRA) collaborative study. Arthritis Rheum. 2003;49:209–15.PubMedCrossRef
19.
Wright NC, Lisse JR, Wallit BT, et al. Arthritis increases the risk for fractures-results from the Women’s Health Initiative. J Rheumatol. 2011;38(8):1680–8.PubMedCentralPubMedCrossRef
20.
Brennan SL, Toomey L, Kotowicz M, et al. Rheumatoid arthritis and incident fracture in women: a case–control study. BMC Musculoskelet Disord.
21.
Vis M, Haavardsholm EA, Boyesen P, et al. High incidence of vertebral and non-vertebral fractures in the OSTRA cohort study: a 5 year follow-up study in postmenopausal women with rheumatoid arthritis. Osteoporos Int. 2011;22:2413–9.PubMedCentralPubMedCrossRef
22.
Genant HK, Wu CY, van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res. 1993;8(9):1137–48.PubMedCrossRef
23.
Dirven L, van den Broek M, van Groenendael JHLM, et al. Prevalence of vertebral fractures in a disease activity steered cohort of patients with early active rheumatoid arthritis. BMC Musculoskelet Disord. 2012;13:125–32.PubMedCentralPubMedCrossRef
24.
Damilakis J, Adams JE, Guglielmi G, Link TM. Radiation exposure in X-ray based imaging techniques used in osteoporosis. Eur Radiol. 2010;20(11):2707–14.PubMedCentralPubMedCrossRef
25.
Lewiecki EM. Bone densitometry and vertebral fracture assessment. Curr Osteoporos Rep. 2010;8:123–30.PubMedCrossRef
26.
Greenspan SL, von Stetten E, Emond SK, et al. Instant vertebral assessment: a noninvasive dual X-ray absorptiometry technique to avoid misclassification and clinical mismanagement of. J Clin Densitom. 2001;3:373–80.CrossRef
27.
Genant HK, Li J, Wu CY, et al. Vertebral fractures in osteoporosis: a new method for clinical assessment. J Clin Densitom. 2000;3:281–90.PubMedCrossRef
28.
Schousboe JT, DeBold CR. Reliability and accuracy of vertebral fracture assessment with densitometry compared to radiography in clinical practice. Osteoporos Int. 2006;17:281–9.PubMedCrossRef
29.
Binkley N, Krueger D, Gangnon R, et al. Lateral vertebral assessment: a valuable technique to assess clinically significant vertebral fractures. Osteoporos Int. 2005;16:1513–8.PubMedCrossRef
30.
National Osteoporosis Foundation. Clinicians guide to prevention and treatment of osteoporosis. Washington, DC: National Osteoporosis Foundation; 2008.
31.
WanWan X, Subashan P, Medich D, et al. Height loss, vertebral fractures and the misclassification of osteoporosis. Bone. 2011;48(2):307–11.CrossRef
32.•
Jager PL, Jonkman S, Koolhas W, et al. Combined vertebral fracture assessment and bone mineral density measurement: a new standard in the diagnosis of osteoporosis in academic populations. Osteoporos Int. 2011;22:1059–68. Large study of 2,424 patients undergoing both DXA and VFA demonstrating the benefit of VFA in changing diagnostic classification by diagnosing asymptomatic vertebral fractures.PubMedCentralPubMedCrossRef
33.
McCloskey EV, Vasireddy S, Threkeld J, et al. Vertebral fracture assessment (VFA) with a densitometer predict future fractures in elderly women unselected for osteoporosis. J Bone Miner Res. 2008;23:1561–8.PubMedCrossRef
34.•
Ghazi M, Kolta S, Briot K, et al. Prevalence of vertebral fractures in patients with rheumatoid arthritis: revisiting the role of glucocorticoids. Osteoporos Int. 2012;23:581–7. Study demonstrating a 16 % prevalence of vertebral fractures by VFA in rheumatoid arthritis patients with osteopenia.PubMedCrossRef
35.
Genant HK, Mitlak BH, Myers S, et al. Radiographic fracture grade is related to clinical disease severity. Results from the rPTH (1–34) fracture prevention study. Arthritis Rheum. 2000;43:S383.
36.
Roux C, Fechtenbaum J, Kolta S, et al. Mild prevalent and incident fractures are risk factors for new fractures. Osteoporos Int. 2007;18:1617–24.PubMedCrossRef
37.•
Lee JH, Cho SK, Han M, et al. Validity and role of vertebral fracture assessment in detecting prevalent vertebral fracture in patients with rheumatoid arthritis. Joint Bone Spine. 2013. doi:10.​1016/​j.​jbspin.​2013.​07.​003. Study demonstrating the high specificity and negative predictive value of VFA in rheumatoid arthritis patients.
38.
Schousboe JT, McKiernan E, Fuehrer JT, et al. Use of a performance algorithm improves utilization of vertebral fracture assessment in clinical practice. Osteoporos Int. 2014;25:965–72.PubMedCrossRef
39.
Rosen HN, Vokes TJ, Malabanan AO, et al. The official positions of the International Society for Clinical Densitometry: vertebral fracture assessment. J Clin Densitom. 2013;16(4):482–8.PubMedCrossRef
40.
Grossman JR, Gordon R, Ranganath VK, et al. American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res. 2010;62:1515–26.CrossRef
41.
Solomon DH, Kremer J, Curtis JR, et al. Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity. Ann Rheum Dis. 2010;69:1920–5.PubMedCentralPubMedCrossRef
42.
Peters MJ, van Halm VP, Voskuyl AE, et al. Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study. Arthritis Rheum. 2009;61:1571–9.PubMedCrossRef
43.
Schousboe JT, Taylor BC, Kiel DP, et al. Abdominal aortic calcification detected on lateral spine images from a bone densitometer predicts incident myocardial infarction or stroke in elderly women. J Bone Miner Res. 2008;23:409–16.PubMedCrossRef
44.••
Mohammad A, Lohan D, Bergin D, et al. Vertebral fracture assessment-detected abdominal aortic calcification and cardiovascular disease in rheumatoid arthritis. Semin Arthritis Rheum. 2013. doi:10.​1016/​j.​semarthrit.​2013.​09.​007. Recent study demonstrating the association of cardiovascular disease with abdominal aortic calcification detected by VFA in rheumatoid arthritis patients.PubMed
45.
Bousson V, Bergot C, Sutter B, et al. Trabecular bone score (TBS): available knowledge, clinical relevance and future prospects. Osteoporos Int. 2012;23:1489–501.PubMedCrossRef
46.••
Silva BC, Leslie WD, Resch H, et al. Trabecular bone score: a noninvasive analytical method based upon the DXA image. J Bone Miner Res. 2014;29:518–30. Comprehensive recent review of trabecular bone score (TBS) including the scientific background and review of studies correlating TBS with prediction of future fracture risk.PubMedCrossRef
47.
Pothuaud L, Carceller P, Hans D. Correlations between gray-level projections in 2D images (TBS) and 3D microarchitecture: applications in the study of human bone trabecular microarchitecture. Bone. 2008;42:775–87.PubMedCrossRef
48.
Briot K, Paternotte S, Kolta S, et al. Added value of trabecular bone score to bone mineral density for the prediction of osteoporotic fractures in postmenopausal women: the OPUS study. Bone. 2013;57(1):232–6.PubMedCrossRef
49.
Winzenrieth R, Dufour R, Pothuaud L, et al. A retrospective case–control study assessing the role of trabecular bone score in postmenopausal Caucasian women with osteopenia: analyzing the odds f vertebral fracture. Calcif Tissue Int. 2010;86(2):104–9.PubMedCrossRef
50.
DelRio LM, Winzenrieth R, Cormier C, et al. Is bone microarchitecture status of the lumbar spine assessed by TBS related to femoral neck fracture? A Spanish case–control study. Osteoporos Int. 2013;24(3):991–8.CrossRef
51.
Krueger D, Fidler E, Libber J, et al. Spine trabecular bone score subsequent to bone mineral density improves fracture risk discrimination in women. J Clin Densitom. 2014;17(1):60–5.PubMedCrossRef
52.•
Hans D, Goertzen AL, Kreig MA, et al. Bone microarchitecture assed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study. J Bone Miner Res. 2011;26(11):2761–8. Large study of 29,307 patients demonstrating the ability of TBS to predict incident fracture risk.CrossRef
53.
Leslie WD, Aubrey-Rozier B, Lamy O, et al. TBS (trabecular bone score) and diabetes-related fracture risk. J Clin Endocrinol Metab. 2013;98(2):602–9.PubMedCrossRef
54.
Breban S, Briot K, Kolta S, et al. Identification of rheumatoid arthritis patients with vertebral fractures using bone mineral density and trabecular bone score. J Clin Densitom. 2012;15(3):260–6.PubMedCrossRef
55.
Colson E, Picar A, Rabier B, et al. Trabecular bone microarchitecture alteration in glucocorticoid treated women in clinical routine a TBS evaluation. J Bone Miner Res. 2009;24(Suppl 1):Abstract
Metadata
Title
Use of DXA-Based Technology for Detection and Assessment of Risk of Vertebral Fracture in Rheumatology Practice
Author
Michael Maricic
Publication date
01-08-2014
Publisher
Springer US
Published in
Current Rheumatology Reports / Issue 8/2014
Print ISSN: 1523-3774
Electronic ISSN: 1534-6307
DOI
https://doi.org/10.1007/s11926-014-0436-5

Other articles of this Issue 8/2014

Current Rheumatology Reports 8/2014 Go to the issue

Complementary and Alternative Medicine (SL Kolasinski, Section Editor)

Ayurvedic Medicine for Rheumatoid Arthritis

VASCULITIS (LR ESPINOZA, SECTION EDITOR)

Treatment of Severe and/or Refractory ANCA-Associated Vasculitis

Inflammatory Muscle Disease (RG Cooper, Section Editor)

Is Statin-Induced Myositis Part of the Polymyositis Disease Spectrum?

RHEUMATOID ARTHRITIS (LW MORELAND, SECTION EDITOR)

Vaccinations for Rheumatoid Arthritis

Pediatric Rheumatology (S Ozen, Section Editor)

Treatment of Uveitis Associated with Juvenile Idiopathic Arthritis

Spondyloarthritis (MA Khan, Section Editor)

Pulmonary, renal and neurological comorbidities in patients with ankylosing spondylitis; implications for clinical practice
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits